Volume 7, Issue 2 pp. 104-109

Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density

Tomohiko Urano

Tomohiko Urano

Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo,

Search for more papers by this author
Masataka Shiraki

Masataka Shiraki

Research Institute and Practice for Involutional Diseases, Nagano, and

Search for more papers by this author
Yasuyoshi Ouchi

Yasuyoshi Ouchi

Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo,

Search for more papers by this author
Satoshi Inoue

Corresponding Author

Satoshi Inoue

Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo,

Research Center for Genomic Medicine, Saitama Medical School, Saitama, Japan

Dr Satoshi Inoue MD, PhD, Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Email: [email protected]Search for more papers by this author
First published: 07 June 2007
Citations: 8

Abstract

Vitamin K2 plays an important role in the bone metabolism. The steroid and xenobiotic receptor (SXR) as a nuclear receptor activated by vitamin K2 as well as rifampicin could increase bone markers such as alkaline phosphatase in human osteoblastic cells. Thus, the SXR could mediate vitamin K2 signaling pathway in bone cells. Therefore, we analyzed expression of the SXR mRNA in human primary osteoblasts and chondrocytes. We also studied association of a single nucleotide polymorphism (SNP) in the SXR gene with bone mineral density (BMD). Expression levels of the SXR mRNA were analyzed during the culture course of human primary osteoblasts and chondrocytes. Association of a SNP in the SXR gene in intron 1 (IVS1-579A>G) with BMD was examined in 294 healthy postmenopausal Japanese women. The SXR mRNA increased at day 5 and then decreased at day 10 in human primary osteoblasts. Its mRNA gradually increased in human primary chondrocytes until day 10. As an association study of a SNP in the SXR gene (IVS1-579A/G), the subjects without the A allele (GG; n = 47) had significantly higher total BMD than the subjects bearing at least one A allele (AA + AG; n = 247) (Z score ± SD; 0.635 ± 1.031 versus 0.268 ± 1.061; P = 0.0298). The SXR mRNA was expressed and regulated in primary human osteoblasts and chondrocytes. A genetic variation at the SXR gene locus is associated with BMD, suggesting an involvement of the SXR gene in human bone metabolism.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.